Stephanie Price
Stephanie is a journalist for Business of Cannabis, writing about science, research, policy and industry developments in cannabis, CBD and psychedelics. In 2013 Stephanie gained her BA in English and Media, focusing on journalism and propaganda, where her magazine 'Game Theory' focused on developments and disruptors over the coming decade including cannabis, psychedelics, blockchain/crypto and free speech. In 2015 Stephanie received her National Council for the Training of Journalists (NCTJ) diploma whilst working as a reporter in North Wales. Stephanie has a specialism in Medical Cannabis: The Health Effects of THC and CBD through the University of Colorado, and a certificate from the Medical Cannabis Clinicians Society on "Medical Cannabis Explained".
Stephanie Price · page 9
- Uncategorized
Measure to be Introduced Preventing Federal Legalisation of Cannabis
U.S. Senators Cynthia Lummis (R-WY) and Steve Daines (R-MT) have announced they will be introducing a new bill that would prevent the federal legalisation of cannabis.
- Uncategorized
CANNRA Calls for Definitions and Regulations on Hemp
The Cannabis Regulators Association (CANNRA) has sent a letter to Congress outlining changes it would like to see to the 2023 Farm Bill.
- Uncategorized
Robust Rule Change for Mississippi Medical Cannabis Market
Mississippi’s Department of Health has announced a proposal for a vigorous change to its medical cannabis market’s regulations.
- Uncategorized
Five Cannabis Operators Shut Down in Oklahoma
The Oklahoma Medical Marijuana Authority (OMMA) has announced it has shut down five cannabis businesses and seized thousands of pounds of illicit cannabis.
- Uncategorized
SAFE Banking Act Text Amended, Scheduled For Mark Up
The text for the SAFE Banking Act that aims to transform banking for the cannabis industry has been amended.
- Uncategorized
Mould Testing on Cannabis Products suspended in Oregon
The Oregon Health Authority (OHA) has filed a temporary suspension on the testing of cannabis products for the mould Aspergillus.
- Uncategorized
New Jersey Proposals Aim to Expand Patient Access and Establish Research Partnerships
New Jersey’s Cannabis Regulatory Commission (CRC) is calling for public feedback on new proposals that seek to expand access to medical cannabis for patients in the state and establish research partnerships between dispensaries and research institutions.
- Uncategorized
Canada Provides $1 Million to GrowerIQ
Cannabis technology company GrowerIQ has secured CAD $1,080,000 in funding from the Government of Canada.
- Uncategorized
Report Reveals $92 Million Cannabis Sales For Florida in August
A new report from Zuanic & Associates has revealed that medical cannabis sales in Florida reached $92 million in August.
- Uncategorized
California Bill Could Prevent Employers From Asking About Cannabis Use
A new bill introduced in California could prevent employers from asking employees about their use of cannabis.
- Uncategorized
CBD Of Denver eröffnet vier Cannabis-Clubs in Deutschland
Im Rahmen seiner europäischen Expansion hat CBD of Denver bekannt gegeben, dass seine hundertprozentige Tochtergesellschaft Luxora vier Absichtserklärungen (Letters of Intent, LoI) zum Bau von Produktionsanlagen für vier Cannabisclubs in Deutschland unterzeichnet hat.
- Uncategorized
CBD Of Denver to Open Four Cannabis Clubs in Germany
As part of its European expansion, CBD of Denver has announced that its wholly owned subsidiary, Luxora, has signed four Letters of Intent (LoI) to build production facilities for four Cannabis Clubs in Germany.
